April 30, 2019

Alcohol Use Disorder: An Overview

Written by: Austin Lin, MD Although the opioid epidemic garners national attention, alcohol use remains a major problem. According to the 2017 National Survey on Drug Use and Health, there were approximately 141 million Americans aged 12 or older who…


April 30, 2019

Diabetes drug could help smokers kick the habit

Phillip Robinson has gone from 10 cigarettes a day to one or two every other day after enrolling in a smoking cessation clinical trial launched by researchers at The University of Texas Health Science Center at Houston (UTHealth). To help…


January 15, 2019

Opioid crisis

Michael Weaver, MD, was interviewed on FOX 26 News this morning about the rise in opioid overdose deaths.


June 16, 2018

Meth addiction has roared back in Texas. Can new experimental treatment stop it?

A UTHealth Psychiatry clinical trial for methamphetamine use was featured in Sunday’s front-page story in the Houston Chronicle with quotes from Joy Schmitz, Ph.D., Michael Weaver, M.D., and trial participants


October 31, 2017

UTHealth receives $2.5 million for HIV education and treatment for persons with substance use disorders

HOUSTON – (Oct. 31, 2017) – A $2.5 million federal grant will allow a multidisciplinary team at The University of Texas Health Science Center at Houston (UTHealth) to provide prevention and treatment information about HIV, AIDS and sexually transmitted diseases…


October 4, 2017

UTHealth researchers receive $2.6 million to study gene-environment interactions in cocaine addiction

HOUSTON – (Oct. 2, 2017) – Studying the effect of environmental stressors on the development of cocaine use is the focus of a $2.6 million award from the National Institutes of Health (NIH) to researchers at McGovern Medical School at…


September 13, 2017

Heads Receives $50,000 Grant from Robert Wood Johnson Foundation

The Robert Wood Johnson Foundation (RWJF), the nation’s leading philanthropy on health and health care, has awarded Angela M. Heads, Ph.D., Assistant Professor in in the UTHealth McGovern Medical School’s, Department of Psychiatry and Behavioral Sciences a 12-month grant through…


June 27, 2017

UTHealth a site for first-ever large NIDA trial for methamphetamine use disorder

With the rates of methamphetamine use reaching an all-time high in Texas, McGovern Medical School researchers have launched a clinical trial designed to treat methamphetamine use disorder. The Center for Neurobehavioral Research on Addiction (CNRA) in the Department of Psychiatry…


December 7, 2016

UTHealth receives NIH grant for treating cocaine addiction

Identifying more effective treatment strategies tailored to individual responses for patients overcoming addiction to cocaine is the focus of a new clinical trial at McGovern Medical School at UTHealth. The study, funded with a $1.9 million grant from the National…


Pages